EMA brings Moderna Covid-19 vaccine decision forward to Jan 6

The Amsterdam-based European Medicines Agency said US-based Moderna had sent extra data ahead of schedule, so the regulator had “scheduled an extraordinary meeting on 6 January 2021 to conclude its assessment, if possible”.

The EU’s medicines watchdog said on Thursday that it had moved forward the date for a decision on authorising Moderna’s coronavirus vaccine to January 6 from January 12.

A second Covid-19 vaccine moved closer to joining the US fight against the pandemic on Dec. 17, 2020. (AP File Photo)

The Amsterdam-based European Medicines Agency said US-based Moderna had sent extra data ahead of schedule, so the regulator had “scheduled an extraordinary meeting on 6 January 2021 to conclude its assessment, if possible”.